NO20060229L - Gaboxadol for behandling av depresjon og andre affektive lidelser - Google Patents

Gaboxadol for behandling av depresjon og andre affektive lidelser

Info

Publication number
NO20060229L
NO20060229L NO20060229A NO20060229A NO20060229L NO 20060229 L NO20060229 L NO 20060229L NO 20060229 A NO20060229 A NO 20060229A NO 20060229 A NO20060229 A NO 20060229A NO 20060229 L NO20060229 L NO 20060229L
Authority
NO
Norway
Prior art keywords
gaboxadol
depression
treatment
affective disorders
pharmaceutical composition
Prior art date
Application number
NO20060229A
Other languages
English (en)
Norwegian (no)
Inventor
Bjarke Ebert
Connie Sanchez
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58707228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20060229(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/DK2004/000459 external-priority patent/WO2004112786A2/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20060229L publication Critical patent/NO20060229L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20060229A 2003-06-25 2006-01-16 Gaboxadol for behandling av depresjon og andre affektive lidelser NO20060229L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200300956 2003-06-25
DKPA200400016 2004-01-07
PCT/DK2004/000459 WO2004112786A2 (en) 2003-06-25 2004-06-25 Gaboxadol for treating depression and other affective disorders

Publications (1)

Publication Number Publication Date
NO20060229L true NO20060229L (no) 2006-01-16

Family

ID=58707228

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060229A NO20060229L (no) 2003-06-25 2006-01-16 Gaboxadol for behandling av depresjon og andre affektive lidelser

Country Status (10)

Country Link
KR (1) KR20060025192A (bs)
AR (1) AR047550A1 (bs)
CA (2) CA2692334A1 (bs)
CL (2) CL2004001607A1 (bs)
EA (1) EA200600101A1 (bs)
IS (1) IS8138A (bs)
ME (2) MEP1908A (bs)
NO (1) NO20060229L (bs)
RS (1) RS20050911A (bs)
TW (1) TW200509918A (bs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3883566A4 (en) 2018-11-21 2022-09-07 Certego Therapeutics Inc. GABOXADOL FOR REDUCE RISK OF SUICIDE AND RAPID RELIEF OF DEPRESSION
US11597726B2 (en) 2020-05-20 2023-03-07 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Also Published As

Publication number Publication date
KR20060025192A (ko) 2006-03-20
AR047550A1 (es) 2006-01-25
CL2004001607A1 (es) 2005-05-27
CL2010000166A1 (es) 2010-07-02
CA2692334A1 (en) 2004-12-29
CA2529805A1 (en) 2004-12-29
RS20050911A (sr) 2007-08-03
TW200509918A (en) 2005-03-16
IS8138A (is) 2005-11-21
MEP1908A (xx) 2010-02-10
ME00030B (me) 2010-06-10
EA200600101A1 (ru) 2006-06-30

Similar Documents

Publication Publication Date Title
IL202106A0 (en) Gaboxadol for treating depression and other affective disorders
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
EA201101190A1 (ru) Фармацевтическая композиция, включающая линаглиптин и необязательно ингибитор sglt2, и ее применение
EA201370208A1 (ru) Формы рифаксимина и их применение
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
EA201101192A1 (ru) Фармацевтическая композиция, включающая производные глюкопиранозилдифенилметана, фармацевтическая дозированная форма, содержащая указанные производные, способ их получения и применения для улучшения гликемического контроля у пациентов
NO20083501L (no) Azaindoler som er anvendelige som inhibitorer for Janus-kinaser
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
EA200700035A1 (ru) Сульфаматные и сульфамидные производные для лечения эпилепсии и родственных di sorders
EA200870019A1 (ru) Лактамовые соединения и способы их применения
NO20060402L (no) 3-amino choman og 2-aminotetralinderivater
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
NO20060242L (no) Kombinasjonen av en serotonin-reopptaksinhibitor og agomelatin
NO20076405L (no) Anvendelse av 24-nor-UDCA
CL2008003231A1 (es) Compuestos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo sustituido, inhibidores selectivos de la recaptacion de serotonina; composicion farmaceutica; procedimiento de preparacion; utiles en el tratamiento y/o prevencion de la eyaculacion prematura.
NO20083751L (no) Metoder for behandling av kognitive og andre sykdommer
DK1937669T3 (da) Nye benzopyranderivater som kaliumkanalåbnere
NO20060229L (no) Gaboxadol for behandling av depresjon og andre affektive lidelser
ATE440836T1 (de) Verbindungen
NO20061425L (no) Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin
ATE524463T1 (de) 4-chromenonyl-1,4-dihydropyridincarbonitrile und ihre verwendung
NO20061427L (no) Kombinasjonen av en serotonin-reoppttaksinhibitor og amoxapin

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application